Nocardiosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Nocardiosis}} {{CMG}} ==Overview== ==Future or Investigational Therapies== A new combination drug therapy (sulfonamide, ceftriaxone, and amikacin) has..." |
m Changes made per Mahshid's request |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
A new combination drug therapy ([[sulfonamide]], [[ceftriaxone]], and [[amikacin]]) has shown promise for treatment of infections not responding to standard antimicrobial treatments. Application of newer molecular diagnostic and subtyping methods may assist in earlier diagnosis. | A new combination drug therapy ([[sulfonamide]], [[ceftriaxone]], and [[amikacin]]) has shown promise for treatment of infections not responding to standard antimicrobial treatments. Application of newer molecular diagnostic and subtyping methods may assist in earlier diagnosis. | ||
Line 10: | Line 9: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category: | |||
[[Category:Bacterial diseases]] | |||
[[Category:Needs overview]] | [[Category:Needs overview]] |
Latest revision as of 18:11, 18 September 2017
Nocardiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Nocardiosis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Nocardiosis future or investigational therapies |
Risk calculators and risk factors for Nocardiosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or Investigational Therapies
A new combination drug therapy (sulfonamide, ceftriaxone, and amikacin) has shown promise for treatment of infections not responding to standard antimicrobial treatments. Application of newer molecular diagnostic and subtyping methods may assist in earlier diagnosis.